✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Genz-10850 is an investigational drug.
There have been 9 clinical trials for Genz-10850. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2010.
The most common disease conditions in clinical trials are Gaucher Disease, Kidney Diseases, and Lipidoses. The leading clinical trial sponsors are Genzyme, a Sanofi Company and [disabled in preview].
Recent Clinical Trials for Genz-10850
|Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy Men||Genzyme, a Sanofi Company||Phase 1|
|Study to Evaluate the Effect of Eliglustat on the Pharmacokinetics, Safety and Tolerability of Metoprolol in Healthy Adults||Genzyme, a Sanofi Company||Phase 1|
|A Phase 1 Study Evaluating Eliglustat's Effects on Pharmacokinetics, Safety & Tolerability of Digoxin in Healthy Adults||Genzyme, a Sanofi Company||Phase 1|